Pfizer CEO says firm plans to ask FDA to authorize FOURTH vaccine dose

The COVID-19 pandemic is showing signs of soon coming to an end as the world marks two years since the World Health Organization (WHO) declared the virus a global pandemic. Some officials are saying that more vaccine shots may be needed in the future even after the world returns to 'normal'.

Albert Bourla, CEO of , told CNBC's Friday morning that his firm plans to ask the Food and Drug Administration () about the needs for a fourth COVID-19 vaccine dose soon. He cites data showing that vaccine protection wanes against after only three or four months.

‘It is clear that there is a need In the environment of Omicron to boost the immune response,’ he said.

Load More